North Dakota State Investment Board’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.4M Sell
23,214
-4,268
-16% -$4.33M 0.92% 17
2025
Q4
$29.5M Buy
+27,482
New +$26.3M 1.1% 16

Other funds holding LLY

North Dakota State Investment Board's LLY Position: Q1 2026 in Review

North Dakota State Investment Board reduced its Eli Lilly (LLY) stake by 16% in Q1 2026, selling an estimated $4.33M and leaving 23,214 shares worth $21.4M. The position accounts for 0.92% of the portfolio, ranked #17.

North Dakota State Investment Board first reported a position in LLY in Q4 2025 and has held it in 2 quarters since. The position peaked at $29.5M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • North Dakota State Investment Board held 23,214 shares of Eli Lilly worth $21.4M as of Q1 2026.
  • North Dakota State Investment Board sold 4,268 Eli Lilly shares in Q1 2026, an estimated $4.33M.
  • Eli Lilly made up 0.92% of North Dakota State Investment Board's portfolio in Q1 2026, its #17 holding.
  • North Dakota State Investment Board first reported a position in Eli Lilly in Q4 2025 and has held it in 2 quarters since.
  • North Dakota State Investment Board's Eli Lilly position peaked at $29.5M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on North Dakota State Investment Board's 13F filing for Q1 2026, filed 8 May 2026.